[
    "Procedure",
    "Construction of AAV vectors",
    "crRNA expression vector ",
    "Design and construction",
    "1.",
    "Identify genes for knockout by targeted delivery of HDR template.",
    "Here we chose TRAC and PDCD1, but note that any gene with a Cpf1 PAM ",
    "Sequence may be targeted.\r\n  ",
    "2.",
    "Design LbCpf1 crRNA \\(20bp) with Benchling or other computational pipelines.\r\n  ",
    "crTRAC: GAGTCTCTCAGCTGGTACAC ",
    "crPDCD1:  GCACGAAGCTCTCCGATGTG",
    "3.",
    "Synthesize oligonucleotides with two LbCpf1 direct repeat and sticky ends.\r\n  ",
    "4.",
    "Digest pXD017 with FD BbsI and insert guide after U6 promoter \\(pXD017-39).\r\n  ",
    "CAR ",
    "Sequence generation",
    "1.",
    "Generation of CD22BBz CAR as previously described 11.",
    "CD22 binding scFV \\(m971) specific for the human CD22 followed by CD8 hinge-transmembrane-regions linked to 4-1BB \\(CD137) intracellular domains and CD3\u03b6 intracellular domain.\r\n  ",
    "2.",
    "The ",
    "Sequence of CD19 binding scFv \\(FMC63) was found from NCBI \\(GenBank: HM852952) and followed by CD8 hinge-transmembrane-regions linked to 4-1BB \\(CD137) intracellular domains and CD3\u03b6 intracellular domain 12.",
    "In order to detect CD19BBz CAR in different way, the Flag-tag ",
    "Sequence \\(GATTACAAAGACGATGACGATAAG) was added after the CD8\u237a leader sequence.\r\n  ",
    "3.   Synthesize m971-BBz and FMC63-BBz using gBlock \\(IDT).\r\n  ",
    "HDR tem",
    "Plate design",
    "1.",
    "Amplify left and right homologous arms of the TRAC or PDCD1 locus from primary CD4+ T cells by PCR using locus-specific primer sets with multiple cloning site \\(MCS).",
    "PCR annealing temperature \\(60\u2103).\r\n  ",
    "TRAC_HDR_F1 \\(With AAV vector overlap sequence) TCAACTAGATCTTGAGACAAGGTACGATGTAAGGAGCTGCTGTGACT",
    "TRAC_HDR_R1 \\(With MCS) GGTACCTCGAGCGTACGGGTCAGGGTTCTGGATATCTGTG",
    "TRAC_HDR_F2 \\(With MCS) CGTACGCTCGAGGTACCGAGAGACTCTAAATCCAGTGACAAG",
    "TRAC_HDR_R2 \\(With AAV vector overlap sequence) CTTTTATTAAGCTTGATATCGAATTGTGGGTTAATGAGTGACTGCG",
    "PDCD1 _",
    "HDR_F1 \\(With AAV vector overlap sequence)  ",
    "TGGCAGGAGAGGGCACGTGGGCAGCCTCACGTAGAAGGAA",
    "PDCD1 _",
    "HDR_R1 \\(With MCS) TCCGAGAATTCTTTGTTAACTGTGTTGGAGAAGCTGCAGGT",
    "PDCD1 _",
    "HDR_F2 \\(With MCS)",
    "CACAGTTAACAAAGAATTCTCGGAGAGCTTCGTGCTAAACTGG",
    "PDCD1 _",
    "HDR_R2 \\(With AAV vector overlap sequence)",
    "GCGGCCGCTCGGTCCGCACCTGATCCTGTGCAGGAGGG",
    "2.",
    "Sequence amplicons \\(Yale Keck or any other Sanger sequencing facility).\r\n  ",
    "AAV-crRNA-HDR-CAR vector cloning",
    "1. pXD040 construction:",
    "Clone HDR sequences into the AAV vector \\(pXD017-39) by Gibson assembly.",
    "Incubate samples in a thermocycler at 50\u00b0C for 30 minutes.  \r\n  ",
    "2. pXD043 \\(CD22CAR) and pXD054 \\(CD19CAR) construction: Digest pXD040 with BsiWI and Acc65I, and then clone CAR sequences into MCS by Gibson assembly.\r\n  ",
    "AAV production and titration",
    "AAV production",
    "1.",
    "Transfect HEK293FT cells with AAV constructs in 15-cm tissue culture dishes, AAV2 transgene vectors, packaging \\(pDF6) plasmid, and AAV6/9 serotype plasmid together with polyethyleneimine \\(PEI).\r\n  ",
    "2.",
    "Collect transfected cells with PBS after 72 hours of transfection.\r\n  ",
    "AAV purification and titration",
    "1.",
    "Mix transfected cells with pure chloroform \\(1/10 volume).\r\n  ",
    "2.",
    "Incubate cells at 37 \u00b0C with ",
    "Shake vigorously for 1 h.\r\n  3.",
    "Add NaCl to a final concentration of 1 M.\r\n  4.",
    "Centrifuge at 20,000g at 4 \u00b0C for 15 mins.\r\n  ",
    "5. Transfer aqueous layer to another tube and ",
    "Discard the chloroform layer.\r\n  ",
    "6.",
    "Add PEG8000 to sample until 10% \\(w/v) and ",
    "Shake until dissolved.\r\n  ",
    "7.",
    "Incubate ",
    "Mix at 4 \u00b0C for 1 h and then ",
    "Centrifuge at 20,000g at 4 \u00b0C.\r\n  8.",
    "Discard supernatant and ",
    "Suspend ",
    "Pellet in DPBS with MgCl2.\r\n  ",
    "9.",
    "Treat sample with universal nuclease and ",
    "Incubate at 37 \u00b0C for 30 mins.\r\n  10.",
    "Add chloroform \\(1:1 volume), shake, and ",
    "Centrifuge at 12,000g at 4\u00b0C for 15 mins.\r\n  11.",
    "Isolate aqueous layer and ",
    "Concentrate through a 100-kDa MWCO.",
    "Critical step: ",
    "Concentrate AAV at high concentration so the volume can be reduced when performing the infection, which can decrease the toxicity of AAV.",
    "AAV should be aliquoted and stored at -80\u2103.\r\n  12.",
    "Titer virus by qPCR using custom Taqman assays \\(ThermoFisher) targeted to promoter U6.\r\n  ",
    "T cell electroporation",
    "1.",
    "Human primary peripheral blood CD4+ T cells were acquired from healthy donors \\(STEMCELL technologies).",
    "T cells were cultured in X-VIVO media \\(Lonza) with 5% human AB serum and recombinant human IL-2 30U/mL.\r\n  2.",
    "Activate T cells with CD3/CD28 Dynabeads for 2 days prior to electroporation.\r\n  ",
    "3. Use magnetic holder to ",
    "Re",
    "Move Dynabeads.\r\n  ",
    "4.",
    "Prepare cells at a density of 2 x 105 cells per 10 \u03bcL tip reaction or 2 x 106 cells per 100 \u03bcL tip reaction in electroporation Buffer R \\(Neon Transfection System Kits).\r\n  ",
    "5. Mixed with 1 \u03bcg or 10 \u03bcg of modified NLS-LbCpf1-NLS mRNA \\(TriLink) according to reaction volume.\r\n  ",
    "6.",
    "Electric shocked at program 24 \\(1,600V, 10ms, and three pulses).\r\n  ",
    "7.",
    "Transfer cells into 200\u00b5l or 1mL of pre-warmed X-VIVO media \\(without antibiotics) immediately after electroporation.\r\n  ",
    "8.",
    "Add indicated volumes of AAV \\(AAV volume to not exceed 20% of culture volume) into the T cells 2-4 hours after electroporation.",
    "CAR will begin to be expressed after two to three days and have enrichment after stimulation with target cells. \r\n  ",
    "CAR-T detection by ",
    "Flow cytometry",
    "1.",
    "After electroporation for 5 days, ",
    "Incubate 1\u00d7106 CD22BBz CAR transduced T cells with 0.2 \u03bcg CD22-Fc \\(R&D system) in 100 \u03bcL PBS for 30 mins, and then ",
    "Stain with PE-IgG-Fc and FITC-CD3 antibodies for 30 mins.\r\n  ",
    "2.",
    "For CD19BBz CAR detection, ",
    "Incubate CD19BBz CAR transduced T cells with APC-anti-DYKDDDDK Tag and FITC-CD3 antibodies for 30 mins.\r\n  3.",
    "Wash cells twice after staining.",
    "Quantify and ",
    "Sort labeled cells on BD FACSAria II.\r\n  ",
    "4.",
    "The staining patterns were analyzed using FlowJo software 9.9.4 \\(Treestar, Ashland, OR).\r\n  ",
    "T7E1 assay",
    "1.",
    "Five days after electroporation, ",
    "Harvest the bulk transduced T cells and sorted T cells.  ",
    "The genomic DNA was collected using the QuickExtract DNA Extraction Solution \\(Epicentre).\r\n  ",
    "2.",
    "PCR ",
    "Amplify target loci from genomic DNA around cutting site.\r\n  ",
    "TRAC_suvF: CTGAGTCCCAGTCCATCACG ",
    "TRAC_suvR:",
    "AGGGTTTTGGTGGCAATGG",
    "            PDCD1_suvF: GTAGGTGCCGCTGTCATTGC ",
    "            PDCD1_suvR: GAGCAGTGCAGACAGGACCA",
    "3.",
    "Run PCR amplicons on 2% E-gel EX and ",
    "Purify \\(with known band size) using QIAquick Gel Extraction Kit.\r\n  4.",
    "After purification, ",
    "Denature 200 ng of purified PCR product, anneal, and ",
    "Digest with T7E1, 37\u2103 45min  \\(New England BioLabs).\r\n  ",
    "5.",
    "Load digested PCR products into 2% E-gel EX and ",
    "Quantify DNA fragment abundance using E-Gel\u2122 Low Range Quantitative DNA Ladder \\(ThermoFisher).\r\n  ",
    "HDR quantification and NGS sequencing analysis",
    "Semi-quantitative In-Out PCR ",
    "1.",
    "Use three primers for In-Out PCR:\r\n               ",
    "TRAC 1st: binds to a ",
    "Sequence from the left TRAC homology arm",
    "             TRAC 2st: binds to genomic ",
    "Sequence outside of this AAV donor ",
    "             CD22CAR 3rd: recognizes a ",
    "Sequence contained in the m971-BBz cassette",
    "TRAC 1st: CCCTTGTCCATCACTGGCAT",
    "TRAC 2st:",
    "GCACACCCCTCATCTGACTT",
    "CD22CAR 3rd: GAAATCAAAGCGGCCGCAG",
    "2.",
    "Normalize amplicon \\(labeled TRAC-HDR) concentration by comparison to the product resulting from the uninfected control with genomic DNA isolated from human CD4+ T cells.\r\n  ",
    "3. PCR products were used for Nextera library preparation following the manufacturer\u2019s protocols \\(Illumina).\r\n  ",
    "4. Prepped libraries were sequenced using 100-bp paired-end reads on an Illumina HiSeq 4000 instrument or equivalent.\r\n  ",
    "Indel quantification ",
    "1.",
    "Some PCR products from amplification around cutting site of genomic DNA \\(same samples as T7E1 assay) were used for Nextera library preparation following the manufacturer\u2019s protocols \\(Illumina).\r\n  ",
    "2. Prepped libraries were sequenced using 100-bp paired-end reads on an Illumina HiSeq 4000 instrument or equivalent \\(generating 29 to 74 million reads per library).\r\n  ",
    "3.",
    "Map paired reads to amplicon sequences \\(expected sequences provided in FASTA form to ",
    "Generate indices) using BWA-MEM with the -M option.\r\n  ",
    "4. Discard 100bp reads in SAM file that fall outside a +/- 75bp window of expected ",
    "Cut site within the amplicon.\r\n  ",
    "5.",
    "Discard soft-clipped reads \\(identified with \u201cS\u201d character in CIGAR string).\r\n  ",
    "6.",
    "Identify indel reads by the presence of \"I\" or \"D\" characters within the CIGAR string.\r\n  ",
    "7.",
    "Quantify cutting efficiency as percentage of indels over total \\(indel plus wild-type reads) within the defined window.\r\n  ",
    "HDR quantification ",
    "1.",
    "Map reads to possible amplicons based on primer combinations and HDR status.\r\n  ",
    "2. Define \"informative\" amplicons as truncated so that 100bp reads would have at least 20bp homology with the CAR ",
    "Sequence \\(or with the other TRAC arm, in the case of wild-type sequences).",
    "Informative reads can be used to distinguish wild-type, NHEJ and HDR reads with higher confidence.\r\n  ",
    "3.",
    "Map paired reads to amplicon sequences using BWA-MEM with -M flag to ",
    "Generate SAM files.\r\n  ",
    "4. Use SAMtools to convert SAM files to BAM, sort, index, and ",
    "Generate summary statistics of ",
    "Read counts with the idxstats option.\r\n  ",
    "5.",
    "To ",
    "Quantify wild-type vs NHEJ reads, ",
    "Take reads that mapped to \u201cinfo_nonHDR\u201d ",
    "Sequence \\(described below), and call reads with indels \\(I\" or \"D\" characters within the CIGAR string) as NHEJ.",
    "Otherwise call reads as wild-type.\r\n  ",
    "6.",
    "Pool ",
    "Read counts for downstream analysis. \r\n  ",
    "7.",
    "Schema for our amplicon sequences and quantifications provided below:\r\n  ",
    "amplicon_nonHDR: refers to full amplicon from F1 and R1 of genomic, wild-type DNA.",
    "amplicon_CAR_F1: refers to full amplicon from F1 and R1 of expected, integrated CAR.",
    "amplicon_CAR_F2: refers to full amplicon from F2 \\(primer site within the CAR as opposed to outside) and R1 of expected, integrated CAR.",
    "info_nonHDR same as amplicon_nonHDR, except truncated to 80bp of the TRAC arms.",
    "info_CAR_F1: same as amplicon_CAR_F1, except truncated to 80bp of the TRAC arms flanking the TRAC-CAR interface.",
    "info_CAR_F2: same as amplicon_CAR_F2, except truncated to 80bp of the TRAC arms flanking the TRAC-CAR interface \\(relevant to the right arm only, since F2 is within the CAR sequence). ",
    "HDR, NHEJ, and WT scores were calculated as follows:",
    "info_nonHDR = info_WT + info_NHEJ",
    "hdr_score = info_CAR_F2/\\(info_CAR_F2+info_nonHDR)",
    "wt_score = info_WT/\\(info_CAR_F2+info_nonHDR)",
    "nhej_score = info_NHEJ/\\(info_CAR_F2+info_nonHDR)",
    "Co-culture functional assays",
    "Stable cell line generation",
    "1.",
    "Generate lentivirus including GFP-Luciferase reporter genes.\r\n  ",
    "2. Infect NALM6 cells \\(ATCC) with 2x concentrated lentivirus by spinoculation in retronectin-coated \\(Takara) plates at 800g for 45 mins at 32\u00b0C.\r\n  ",
    "3.",
    "After infection for 2 days, ",
    "Sort GFP positive cells \\(NALM6-GL) by ",
    "Flow cytometry.\r\n  ",
    "4. Perform a second round of sorting after culturing for an additional two days.\r\n  ",
    "5.",
    "Incubate cells with 150g/ml D-Luciferin \\(PerkinElmer) and ",
    "Measure bioluminescence signal intensity by an IVIS system to ",
    "Assess luciferase expression.\r\n  ",
    "Cancer cell cytolytic assay \\(kill assay)",
    "1.",
    "Seed 2104  NALM6-GL cells in a 96 well plate.\r\n  ",
    "2.",
    "Co-culture modified T cells with NALM6-GL at indicated E:T ratios for 24 hours.\r\n  ",
    "3.",
    "Add 150g/ml D-Luciferin \\(PerkinElmer) into each well and ",
    "Measure luciferase assay intensity by a ",
    "Plate reader \\(PerkinElmer) to ",
    "Assess cell proliferation.\r\n  ",
    "T cell exhaustion assay ",
    "1.",
    "Co-culture T cells modified by AAV with NALM6-GL cells at 0.5:1 E:T ratio for 24 hours.\r\n  ",
    "2.",
    "Collect cells and ",
    "Wash once by DPBS.",
    "Incubate cells with 0.2 \u03bcg CD22-Fc \\(R&D Systems) in 100 \u03bcL DPBS for 30 mins.\r\n  ",
    "3.",
    "Stain cells with PE-IgG-Fc, PD-1-FITC, TIGIT-APC and LAG3-Percp/cy5.5 \\(Biolegend) for 30 mins.\r\n  ",
    "4.",
    "Measure stained cells by ",
    "Flow cytometry.\r\n  ",
    "Intracellular staining of IFN\u03b3 and TNF-",
    "1.",
    "After infection for 5 days, co-culture AAV transduced CD22BBz CAR-T cells with NALM6 at 1:1 E:T ratio in fresh media supplemented with brefeldin A and 2 ng/mL IL-2.\r\n  ",
    "2.",
    "After 5 hours of incubation, ",
    "Collect and ",
    "Stain for surface CAR.\r\n  ",
    "3.",
    "Fix and permeabilize cells by fixation/permeabilization solution \\(BD) and ",
    "Add anti-IFN\u03b3-APC or anti-TNF--FITC for intracellular staining.\r\n  ",
    "4.",
    "After 30 mins, ",
    "Wash stained cells by BD Perm/Wash\u2122 buffer and ",
    "Measure cells by ",
    "Flow cytometry."
]